Cargando…

Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance

Nerve growth factor (NGF) contributes to the progression of malignancy. However, the functional role and regulatory mechanisms of NGF in the development of neuroendocrine prostate cancer (NEPC) are unclear. Here, we show that an androgen-deprivation therapy (ADT)-stimulated transcription factor, ZBT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wei-Yu, Wen, Yu-Ching, Lin, Shian-Ren, Yeh, Hsiu-Lien, Jiang, Kuo-Ching, Chen, Wei-Hao, Lin, Yow-Sien, Zhang, Qingfu, Liew, Phui-Ly, Hsiao, Michael, Huang, Jiaoti, Liu, Yen-Nien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782543/ https://www.ncbi.nlm.nih.gov/pubmed/33398073 http://dx.doi.org/10.1038/s42003-020-01549-1

Ejemplares similares

CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer
por: Wen, Yu-Ching, et al.
Publicado: (2023)

TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer
por: Wen, Yu-Ching, et al.
Publicado: (2021)

Pyruvate kinase L/R links metabolism dysfunction to neuroendocrine differentiation of prostate cancer by ZBTB10 deficiency
por: Wen, Yu-Ching, et al.
Publicado: (2022)

Polymorphisms in the Cholinergic Receptors Muscarinic (CHRM2 and CHRM3) Genes and Alzheimer’s Disease
por: Chee, Lim Ya, et al.
Publicado: (2018)

Interplay of Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 3 in Prostate Cancer: Beyond Androgen Receptor Transactivation
por: Lin, Shian-Ren, et al.
Publicado: (2021)

The Functional Haplotypes of CHRM3 Modulate mRNA Expression and Associate with Bladder Cancer among a Chinese Han Population in Kaohsiung City
por: Wang, Chiang-Ting, et al.
Publicado: (2016)

Pancreas-specific CHRM3 activation causes pancreatitis in mice
por: Wan, Jianhua, et al.
Publicado: (2021)

Sex, Age, and Regional Differences in CHRM1 and CHRM3 Genes Expression Levels in the Human Brain Biopsies: Potential Targets for Alzheimer's Disease-related Sleep Disturbances
por: Sanfilippo, Cristina, et al.
Publicado: (2023)

Network toxicology and molecular docking analyses on strychnine indicate CHRM1 is a potential neurotoxic target
por: Dai, Jialin, et al.
Publicado: (2022)

A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans
por: Cheng, Zhongshan, et al.
Publicado: (2019)

A homozygous missense variant in CHRM3 associated with familial urinary bladder disease
por: Beaman, Glenda M., et al.
Publicado: (2019)

Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction
por: Chang, Shih-Ching, et al.
Publicado: (2020)

Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
por: Lin, Yu-Chien, et al.
Publicado: (2020)

Impaired sweating in patients with cholinergic urticaria is linked to low expression of acetylcholine receptor CHRM3 and acetylcholine esterase in sweat glands
por: Wang, Yiyu, et al.
Publicado: (2022)

MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer
por: Bhagirath, Divya, et al.
Publicado: (2020)

Evaluation of Dietary Intake in Individuals with Mild Cognitive Impairment
por: Nien, Shih-Wei, et al.
Publicado: (2023)

The role of glutamine metabolism in castration-resistant prostate cancer
por: Zhao, Bing, et al.
Publicado: (2023)

BHLHE22 Expression Is Associated with a Proinflammatory Immune Microenvironment and Confers a Favorable Prognosis in Endometrial Cancer
por: Darmawi,, et al.
Publicado: (2022)

CHRM3 is a novel prognostic factor of poor prognosis and promotes glioblastoma progression via activation of oncogenic invasive growth factors
por: ZHANG, BIN, et al.
Publicado: (2023)

The Crosstalk of Long Non-Coding RNA and MicroRNA in Castration-Resistant and Neuroendocrine Prostate Cancer: Their Interaction and Clinical Importance
por: Hu, Che-Yuan, et al.
Publicado: (2021)

Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms
por: Butler, William, et al.
Publicado: (2021)

Engineer design process assisted by explainable deep learning network
por: Hsu, Chia-Wei, et al.
Publicado: (2021)

Prediction of Bone Healing around Dental Implants in Various Boundary Conditions by Deep Learning Network
por: Kung, Pei-Ching, et al.
Publicado: (2023)

Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis
por: Chu, Ling-Hui, et al.
Publicado: (2022)

Antidiabetic and Antihyperlipidemic Effects of Sulphurenic Acid, a Triterpenoid Compound from Antrodia camphorata, in Streptozotocin-Induced Diabetic Mice
por: Lin, Cheng-Hsiu, et al.
Publicado: (2019)

New classification may assist the development of targeted therapies for treatment-refractory castration-resistant prostate cancer
por: Lin, Ching-Yu, et al.
Publicado: (2020)

Targeting androgen receptor and the variants by an orally bioavailable Proteolysis Targeting Chimeras compound in castration resistant prostate cancer
por: Hung, Chiu-Lien, et al.
Publicado: (2023)

Cost Utility Analysis of Multidisciplinary Postacute Care for Stroke: A Prospective Six-Hospital Cohort Study
por: Chen, Yu-Ching, et al.
Publicado: (2022)

Unknown‑primary neuroendocrine neoplasms diagnosed by short‑acting somatostatin test: Case series in one institution
por: Chang, Tsung-Kun, et al.
Publicado: (2022)

MicroRNA-30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3
por: Zheng, Xin-Min, et al.
Publicado: (2018)

Exploring the functional role of the CHRM2 gene in human cognition: results from a dense genotyping and brain expression study
por: Gosso, Florencia M, et al.
Publicado: (2007)

CHRM3 rs2165870 Polymorphism Correlates with Postoperative Nausea and Vomiting Incidence and the Efficacy of Ondansetron in a Chinese Han Population
por: Wang, Jiayu, et al.
Publicado: (2020)

DEF6 expression in ovarian carcinoma correlates with poor patient survival
por: Liew, Phui-Ly, et al.
Publicado: (2016)

Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer
por: Wen, Yu‐Ching, et al.
Publicado: (2023)

Predicting 30-Day Readmission for Stroke Using Machine Learning Algorithms: A Prospective Cohort Study
por: Chen, Yu-Ching, et al.
Publicado: (2022)

Clinicopathologic and Prognostic Significance of Thymopoietin-α Overexpression in Gastric Cancer
por: Sun, Ding-Ping, et al.
Publicado: (2019)

Divergent clonal evolution of castration resistant neuroendocrine prostate cancer
por: Beltran, Himisha, et al.
Publicado: (2016)

Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone—A Retrospective Study
por: Chen, Hao Xiang, et al.
Publicado: (2023)

Neuroendocrine Differentiation in Prostate Cancer: A Mechanism of Radioresistance and Treatment Failure
por: Hu, Chang-Deng, et al.
Publicado: (2015)

The new SRS/FSRT technique HyperArc for benign brain lesions: a dosimetric analysis
por: Ho, Hsiu-Wen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9aegjris6p8ij569lc5e0ok3p3